Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

PROTO1 and PROTO2 protect against hearing damage.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Grape seed extract may safely and effectively help prevent lung cancer.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Early balding at 40 increases prostate cancer risk.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Innovative methods are reducing animal testing and improving biomedical research.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.